BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31425556)

  • 1. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
    Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
    PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
    Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
    Chagtai T; Zill C; Dainese L; Wegert J; Savola S; Popov S; Mifsud W; Vujanić G; Sebire N; Le Bouc Y; Ambros PF; Kager L; O'Sullivan MJ; Blaise A; Bergeron C; Mengelbier LH; Gisselsson D; Kool M; Tytgat GA; van den Heuvel-Eibrink MM; Graf N; van Tinteren H; Coulomb A; Gessler M; Williams RD; Pritchard-Jones K
    J Clin Oncol; 2016 Sep; 34(26):3195-203. PubMed ID: 27432915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
    Groenendijk A; van Tinteren H; Jiang Y; de Krijger RR; Vujanic GM; Godzinski J; Rübe C; Schenk JP; Morosi C; Pritchard-Jones K; Al-Saadi R; Vaidya SJ; Verschuur AC; Ramírez-Villar GL; Graf N; de Camargo B; Drost J; Perotti D; van den Heuvel-Eibrink MM; Brok J; Spreafico F; Mavinkurve-Groothuis AMC
    Eur J Cancer; 2022 Mar; 163():88-97. PubMed ID: 35042071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Wilms tumour.
    Zdrojowy R; Sawicz-Birkowska K; Apoznański W; Patkowski D; Szydełko T; Pietras W; Dembowski J
    Int Urol Nephrol; 2011 Sep; 43(3):691-6. PubMed ID: 21110097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
    van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
    Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephroblastoma -  30-years period of its treatment in the University Hospital Motol, Prague].
    Mališ J; Švojgr K; Pýcha K; Jeřábková V; Cyprová S; Churáčková M; Šmelhaus V; Radvanský J; Zítková M; Kodet R; Kodetová D; Malinová B; Koutecký J; Šnajdauf J; Starý J
    Klin Onkol; 2013; 26(5):336-42. PubMed ID: 24107156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial.
    Irtan S; Van Tinteren H; Graf N; van den Heuvel-Eibrink MM; Heij H; Bergeron C; de Camargo B; Acha T; Spreafico F; Vujanic G; Powis M; Okoye B; Wilde J; Godzinski J; Pritchard-Jones K
    Eur J Cancer; 2019 Jul; 116():13-20. PubMed ID: 31163337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Wilms tumors: Treatment results from a single center.
    Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T
    Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology.
    Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N
    Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.
    Irtan S; Messahel B; Moroz V; Taylor RE; Grundy R; Kelsey A; Vujanic G; Pritchard-Jones K;
    Radiother Oncol; 2019 Feb; 131():1-7. PubMed ID: 30773174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
    Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.